

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 7.27069903 |
| 2 | surfactant homeostasis (GO:0043129) | 7.06845998 |
| 3 | sodium ion export (GO:0071436) | 6.70827241 |
| 4 | alanine transport (GO:0032328) | 6.58822025 |
| 5 | thyroid hormone generation (GO:0006590) | 6.48073994 |
| 6 | L-amino acid import (GO:0043092) | 6.43161783 |
| 7 | amino acid import (GO:0043090) | 6.27145622 |
| 8 | chemical homeostasis within a tissue (GO:0048875) | 6.08226841 |
| 9 | cellular sodium ion homeostasis (GO:0006883) | 5.98086841 |
| 10 | gamma-aminobutyric acid transport (GO:0015812) | 5.93717456 |
| 11 | L-serine transport (GO:0015825) | 5.42686661 |
| 12 | potassium ion import (GO:0010107) | 5.35298778 |
| 13 | thyroid hormone metabolic process (GO:0042403) | 5.33140240 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.29008189 |
| 15 | C4-dicarboxylate transport (GO:0015740) | 5.09144183 |
| 16 | neurotransmitter uptake (GO:0001504) | 4.97482087 |
| 17 | cell communication by electrical coupling (GO:0010644) | 4.97222084 |
| 18 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 4.88521106 |
| 19 | potassium ion homeostasis (GO:0055075) | 4.74039957 |
| 20 | serine transport (GO:0032329) | 4.71346911 |
| 21 | one-carbon compound transport (GO:0019755) | 4.68472147 |
| 22 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.48070575 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.47966407 |
| 24 | axon ensheathment in central nervous system (GO:0032291) | 4.46477934 |
| 25 | central nervous system myelination (GO:0022010) | 4.46477934 |
| 26 | cellular response to cholesterol (GO:0071397) | 4.22334881 |
| 27 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.14047835 |
| 28 | low-density lipoprotein particle remodeling (GO:0034374) | 4.10675071 |
| 29 | negative regulation of astrocyte differentiation (GO:0048712) | 4.06985303 |
| 30 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.02589950 |
| 31 | negative regulation of sodium ion transport (GO:0010766) | 3.97468678 |
| 32 | negative regulation of complement activation (GO:0045916) | 3.93901074 |
| 33 | regulation of respiratory system process (GO:0044065) | 3.90873830 |
| 34 | positive regulation of p38MAPK cascade (GO:1900745) | 3.83912716 |
| 35 | nephron tubule formation (GO:0072079) | 3.82711970 |
| 36 | ovulation cycle (GO:0042698) | 3.79002854 |
| 37 | cellular response to sterol (GO:0036315) | 3.63635219 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.61038517 |
| 39 | sodium ion homeostasis (GO:0055078) | 3.59956583 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 3.56287492 |
| 41 | locomotory exploration behavior (GO:0035641) | 3.54329043 |
| 42 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.49957116 |
| 43 | acidic amino acid transport (GO:0015800) | 3.46473891 |
| 44 | negative regulation of protein activation cascade (GO:2000258) | 3.46435903 |
| 45 | cerebellar granule cell differentiation (GO:0021707) | 3.45245992 |
| 46 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.44049463 |
| 47 | hyperosmotic salinity response (GO:0042538) | 3.38009017 |
| 48 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.36056970 |
| 49 | thyroid gland development (GO:0030878) | 3.35845710 |
| 50 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.35644574 |
| 51 | membrane assembly (GO:0071709) | 3.34273112 |
| 52 | negative regulation of humoral immune response (GO:0002921) | 3.32746552 |
| 53 | cellular response to nitric oxide (GO:0071732) | 3.30566926 |
| 54 | regulation of cilium movement (GO:0003352) | 3.28966046 |
| 55 | proline transport (GO:0015824) | 3.25563826 |
| 56 | negative regulation of protein localization to cell surface (GO:2000009) | 3.25527324 |
| 57 | cellular response to reactive nitrogen species (GO:1902170) | 3.20678297 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 3.19709488 |
| 59 | multicellular organismal water homeostasis (GO:0050891) | 3.19168768 |
| 60 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.16595225 |
| 61 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.16218500 |
| 62 | relaxation of cardiac muscle (GO:0055119) | 3.14006792 |
| 63 | regulation of respiratory gaseous exchange (GO:0043576) | 3.13410447 |
| 64 | response to auditory stimulus (GO:0010996) | 3.10127056 |
| 65 | presynaptic membrane assembly (GO:0097105) | 3.05462594 |
| 66 | drinking behavior (GO:0042756) | 3.05255801 |
| 67 | regulation of actin filament-based movement (GO:1903115) | 3.00918282 |
| 68 | mechanosensory behavior (GO:0007638) | 2.99880762 |
| 69 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.98173603 |
| 70 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.97376631 |
| 71 | oligodendrocyte differentiation (GO:0048709) | 2.97012877 |
| 72 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.96992849 |
| 73 | adenine nucleotide transport (GO:0051503) | 2.96692760 |
| 74 | L-glutamate transport (GO:0015813) | 2.95703436 |
| 75 | regulation of activation of Janus kinase activity (GO:0010533) | 2.95592093 |
| 76 | postsynaptic membrane organization (GO:0001941) | 2.94489288 |
| 77 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.93898855 |
| 78 | synaptic transmission, glutamatergic (GO:0035249) | 2.93493056 |
| 79 | renal absorption (GO:0070293) | 2.91204967 |
| 80 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.90816391 |
| 81 | neuron cell-cell adhesion (GO:0007158) | 2.90564374 |
| 82 | tonic smooth muscle contraction (GO:0014820) | 2.89785667 |
| 83 | atrial cardiac muscle cell action potential (GO:0086014) | 2.88633501 |
| 84 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.88329471 |
| 85 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.87310711 |
| 86 | regulation of astrocyte differentiation (GO:0048710) | 2.87043980 |
| 87 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.86913044 |
| 88 | negative regulation of tissue remodeling (GO:0034104) | 2.86639397 |
| 89 | appendage development (GO:0048736) | 2.83681038 |
| 90 | limb development (GO:0060173) | 2.83681038 |
| 91 | regulation of heat generation (GO:0031650) | 2.83559783 |
| 92 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.82817183 |
| 93 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.81105847 |
| 94 | astrocyte differentiation (GO:0048708) | 2.80594082 |
| 95 | cellular response to leptin stimulus (GO:0044320) | 2.80585507 |
| 96 | chondroitin sulfate catabolic process (GO:0030207) | 2.79528208 |
| 97 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.79430666 |
| 98 | regulation of alkaline phosphatase activity (GO:0010692) | 2.78124964 |
| 99 | nonmotile primary cilium assembly (GO:0035058) | 2.75634798 |
| 100 | detection of temperature stimulus (GO:0016048) | 2.75361655 |
| 101 | metanephric nephron tubule development (GO:0072234) | 2.75281297 |
| 102 | metanephric tubule development (GO:0072170) | 2.75281297 |
| 103 | vascular smooth muscle contraction (GO:0014829) | 2.75205326 |
| 104 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.73054898 |
| 105 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.71804215 |
| 106 | L-amino acid transport (GO:0015807) | 2.71539547 |
| 107 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.71074430 |
| 108 | auditory behavior (GO:0031223) | 2.70027426 |
| 109 | presynaptic membrane organization (GO:0097090) | 2.68739982 |
| 110 | establishment of skin barrier (GO:0061436) | 2.67402357 |
| 111 | cilium movement (GO:0003341) | 2.65701261 |
| 112 | peripheral nervous system axon ensheathment (GO:0032292) | 2.64429823 |
| 113 | myelination in peripheral nervous system (GO:0022011) | 2.64429823 |
| 114 | neuronal action potential propagation (GO:0019227) | 2.63025840 |
| 115 | water homeostasis (GO:0030104) | 2.62219019 |
| 116 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.61126550 |
| 117 | Golgi to plasma membrane protein transport (GO:0043001) | 2.60824928 |
| 118 | positive regulation of phosphatase activity (GO:0010922) | 2.60497726 |
| 119 | neuromuscular junction development (GO:0007528) | 2.60334539 |
| 120 | phosphate ion transmembrane transport (GO:0035435) | 2.60268288 |
| 121 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.59820280 |
| 122 | regulation of protein glycosylation (GO:0060049) | 2.58588515 |
| 123 | cell communication involved in cardiac conduction (GO:0086065) | 2.56530528 |
| 124 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.55598378 |
| 125 | purine nucleotide transport (GO:0015865) | 2.55280980 |
| 126 | negative regulation of neurotransmitter transport (GO:0051589) | 2.53934019 |
| 127 | response to cholesterol (GO:0070723) | 2.52990095 |
| 128 | metanephric nephron epithelium development (GO:0072243) | 2.52829170 |
| 129 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.52181609 |
| 130 | protein heterotetramerization (GO:0051290) | 2.52130997 |
| 131 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.51206631 |
| 132 | neutral amino acid transport (GO:0015804) | 2.51094671 |
| 133 | brain morphogenesis (GO:0048854) | 2.50835579 |
| 134 | dendrite morphogenesis (GO:0048813) | 2.50350298 |
| 135 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.50091504 |
| 136 | long-term memory (GO:0007616) | 2.49473268 |
| 137 | vocalization behavior (GO:0071625) | 2.49218211 |
| 138 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.49075645 |
| 139 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.48251966 |
| 140 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.46811488 |
| 141 | lipid translocation (GO:0034204) | 2.44965910 |
| 142 | phospholipid translocation (GO:0045332) | 2.44965910 |
| 143 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.44029014 |
| 144 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.44010171 |
| 145 | artery smooth muscle contraction (GO:0014824) | 2.43261990 |
| 146 | regulation of water loss via skin (GO:0033561) | 2.42909160 |
| 147 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.42769353 |
| 148 | phosphate ion transport (GO:0006817) | 2.41836172 |
| 149 | regulation of membrane repolarization (GO:0060306) | 2.41498321 |
| 150 | cGMP-mediated signaling (GO:0019934) | 2.41332993 |
| 151 | hair follicle development (GO:0001942) | 2.40918253 |
| 152 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40449279 |
| 153 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.40295081 |
| 154 | fatty acid elongation (GO:0030497) | 2.40198636 |
| 155 | regulation of beta-amyloid formation (GO:1902003) | 2.39879434 |
| 156 | response to leptin (GO:0044321) | 2.39867289 |
| 157 | plasma lipoprotein particle organization (GO:0071827) | 2.39621685 |
| 158 | negative regulation of heart contraction (GO:0045822) | 2.39565076 |
| 159 | negative regulation of muscle contraction (GO:0045932) | 2.39067837 |
| 160 | glycine transport (GO:0015816) | 2.39016553 |
| 161 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.38205729 |
| 162 | response to histamine (GO:0034776) | 2.38016018 |
| 163 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.37580081 |
| 164 | negative regulation of glial cell differentiation (GO:0045686) | 2.37536438 |
| 165 | establishment of nucleus localization (GO:0040023) | 2.36809658 |
| 166 | photoreceptor cell differentiation (GO:0046530) | 2.35083881 |
| 167 | eye photoreceptor cell differentiation (GO:0001754) | 2.35083881 |
| 168 | regulation of complement activation (GO:0030449) | 2.33014158 |
| 169 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.31328041 |
| 170 | astrocyte development (GO:0014002) | 2.31034678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38553473 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.04741176 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79468002 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.74111005 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.64484369 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51774709 |
| 7 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47457481 |
| 8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35919145 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.32911437 |
| 10 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23838322 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19497706 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18113475 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18113475 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14859923 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10348599 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.10270888 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.09228181 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08040503 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01247018 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97130993 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94019090 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93672990 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92654580 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91432380 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.90131088 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.84714323 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79206597 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77986293 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73216875 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71865787 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70152129 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64808637 |
| 33 | RXR_22108803_ChIP-Seq_LS180_Human | 1.58323273 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57930860 |
| 35 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57672349 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56334460 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.52238523 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49343873 |
| 39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.48807071 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47657569 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47571357 |
| 42 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.47057990 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45402400 |
| 44 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.45142330 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44486885 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43629873 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43370051 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41874521 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41515978 |
| 50 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.40946833 |
| 51 | CJUN_26792858_Chip-Seq_BT549_Human | 1.39175348 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39089612 |
| 53 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.36751357 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36133231 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34110344 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33157572 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32291655 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29688973 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.29149881 |
| 60 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23513685 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23011733 |
| 62 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22591818 |
| 63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22004351 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20250758 |
| 65 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19861227 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19086380 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18243492 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17146263 |
| 69 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16966711 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16809655 |
| 71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16755306 |
| 72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16418042 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16230064 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16019111 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.13805531 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13639374 |
| 77 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12471580 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12128466 |
| 79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11544420 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11414267 |
| 81 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11414267 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11078946 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11010399 |
| 84 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10536723 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10467568 |
| 86 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.10422164 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09187336 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08705604 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08136024 |
| 90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07603483 |
| 91 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07438701 |
| 92 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06447876 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05786498 |
| 94 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03850137 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03678282 |
| 96 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03113371 |
| 97 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03079904 |
| 98 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.03069425 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02915350 |
| 100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02850368 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02741846 |
| 102 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02224882 |
| 103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.01998594 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01339614 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00804706 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98827371 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98472825 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98472825 |
| 109 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98094402 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98030330 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97717444 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97401300 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96860862 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95887815 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.95878590 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95771207 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94795573 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93886700 |
| 119 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93849590 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91941576 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91066790 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90107022 |
| 123 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90070635 |
| 124 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.89759132 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88801762 |
| 126 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88040743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.89863960 |
| 2 | MP0004782_abnormal_surfactant_physiolog | 4.43233120 |
| 3 | MP0005423_abnormal_somatic_nervous | 4.36561418 |
| 4 | MP0004885_abnormal_endolymph | 4.25539942 |
| 5 | MP0004270_analgesia | 3.67363604 |
| 6 | MP0000383_abnormal_hair_follicle | 3.51731924 |
| 7 | MP0001984_abnormal_olfaction | 3.24297459 |
| 8 | MP0010368_abnormal_lymphatic_system | 3.22777160 |
| 9 | MP0003878_abnormal_ear_physiology | 3.14348057 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 3.14348057 |
| 11 | MP0002254_reproductive_system_inflammat | 3.14340694 |
| 12 | MP0004858_abnormal_nervous_system | 3.13621693 |
| 13 | MP0003690_abnormal_glial_cell | 3.12266502 |
| 14 | MP0005171_absent_coat_pigmentation | 3.00720206 |
| 15 | MP0010678_abnormal_skin_adnexa | 2.96244810 |
| 16 | MP0009046_muscle_twitch | 2.94764392 |
| 17 | MP0000681_abnormal_thyroid_gland | 2.74789614 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.73732046 |
| 19 | MP0000566_synostosis | 2.63924658 |
| 20 | MP0001486_abnormal_startle_reflex | 2.54632391 |
| 21 | MP0009384_cardiac_valve_regurgitation | 2.48059943 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.44732972 |
| 23 | MP0001485_abnormal_pinna_reflex | 2.31849356 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 2.29683464 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.27157399 |
| 26 | MP0005388_respiratory_system_phenotype | 2.05936465 |
| 27 | MP0002133_abnormal_respiratory_system | 2.05936465 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.99550389 |
| 29 | MP0002064_seizures | 1.97633690 |
| 30 | MP0009745_abnormal_behavioral_response | 1.90508648 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.89326533 |
| 32 | MP0008004_abnormal_stomach_pH | 1.81561202 |
| 33 | MP0002653_abnormal_ependyma_morphology | 1.78970136 |
| 34 | MP0003633_abnormal_nervous_system | 1.78914820 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.75957016 |
| 36 | MP0002063_abnormal_learning/memory/cond | 1.73055452 |
| 37 | MP0005023_abnormal_wound_healing | 1.71281443 |
| 38 | MP0008995_early_reproductive_senescence | 1.68438219 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.63165346 |
| 40 | MP0002272_abnormal_nervous_system | 1.62849777 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.61742512 |
| 42 | MP0001851_eye_inflammation | 1.57213043 |
| 43 | MP0003329_amyloid_beta_deposits | 1.55578417 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.55507427 |
| 45 | MP0003634_abnormal_glial_cell | 1.54455421 |
| 46 | MP0002089_abnormal_postnatal_growth/wei | 1.52895421 |
| 47 | MP0004742_abnormal_vestibular_system | 1.51598246 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.49934073 |
| 49 | MP0002736_abnormal_nociception_after | 1.47796708 |
| 50 | MP0008569_lethality_at_weaning | 1.44122140 |
| 51 | MP0003879_abnormal_hair_cell | 1.43392787 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.43238658 |
| 53 | MP0004043_abnormal_pH_regulation | 1.41519894 |
| 54 | MP0003880_abnormal_central_pattern | 1.40812302 |
| 55 | MP0003631_nervous_system_phenotype | 1.40249938 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.40019030 |
| 57 | MP0004142_abnormal_muscle_tone | 1.38695952 |
| 58 | MP0005275_abnormal_skin_tensile | 1.35689582 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.33033779 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.26294511 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.25950788 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.25394058 |
| 63 | MP0002098_abnormal_vibrissa_morphology | 1.20979959 |
| 64 | MP0003091_abnormal_cell_migration | 1.18442888 |
| 65 | MP0003075_altered_response_to | 1.17241048 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.17175228 |
| 67 | MP0000579_abnormal_nail_morphology | 1.14573438 |
| 68 | MP0003950_abnormal_plasma_membrane | 1.11346642 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.10876638 |
| 70 | MP0000778_abnormal_nervous_system | 1.10456258 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.10278181 |
| 72 | MP0003115_abnormal_respiratory_system | 1.08026968 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.07745545 |
| 74 | MP0000604_amyloidosis | 1.07719228 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.07586429 |
| 76 | MP0000920_abnormal_myelination | 1.06729910 |
| 77 | MP0001958_emphysema | 1.06135397 |
| 78 | MP0002733_abnormal_thermal_nociception | 1.05960601 |
| 79 | MP0001963_abnormal_hearing_physiology | 1.05758231 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.04261227 |
| 81 | MP0001853_heart_inflammation | 1.04196117 |
| 82 | MP0000049_abnormal_middle_ear | 1.04024478 |
| 83 | MP0003632_abnormal_nervous_system | 1.03267144 |
| 84 | MP0001299_abnormal_eye_distance/ | 1.01682255 |
| 85 | MP0005386_behavior/neurological_phenoty | 0.98317671 |
| 86 | MP0004924_abnormal_behavior | 0.98317671 |
| 87 | MP0002822_catalepsy | 0.98209507 |
| 88 | MP0002295_abnormal_pulmonary_circulatio | 0.98202591 |
| 89 | MP0002168_other_aberrant_phenotype | 0.97141660 |
| 90 | MP0005409_darkened_coat_color | 0.96602655 |
| 91 | MP0001970_abnormal_pain_threshold | 0.96364153 |
| 92 | MP0006138_congestive_heart_failure | 0.95916845 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.95270803 |
| 94 | MP0000026_abnormal_inner_ear | 0.94033722 |
| 95 | MP0000377_abnormal_hair_follicle | 0.93734785 |
| 96 | MP0002882_abnormal_neuron_morphology | 0.93147918 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.92273424 |
| 98 | MP0005165_increased_susceptibility_to | 0.89616524 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.88691101 |
| 100 | MP0002229_neurodegeneration | 0.85831611 |
| 101 | MP0005164_abnormal_response_to | 0.85570836 |
| 102 | MP0004272_abnormal_basement_membrane | 0.83809487 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.83242195 |
| 104 | MP0002066_abnormal_motor_capabilities/c | 0.82991097 |
| 105 | MP0004484_altered_response_of | 0.82436165 |
| 106 | MP0000427_abnormal_hair_cycle | 0.81717442 |
| 107 | MP0000955_abnormal_spinal_cord | 0.81629417 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.81133055 |
| 109 | MP0002152_abnormal_brain_morphology | 0.80567915 |
| 110 | MP0002796_impaired_skin_barrier | 0.80547007 |
| 111 | MP0004084_abnormal_cardiac_muscle | 0.80265923 |
| 112 | MP0005253_abnormal_eye_physiology | 0.80070611 |
| 113 | MP0003045_fibrosis | 0.80040004 |
| 114 | MP0001177_atelectasis | 0.79680803 |
| 115 | MP0004883_abnormal_blood_vessel | 0.79112560 |
| 116 | MP0002735_abnormal_chemical_nociception | 0.77622823 |
| 117 | MP0004036_abnormal_muscle_relaxation | 0.77176037 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.76298046 |
| 119 | MP0000613_abnormal_salivary_gland | 0.76060910 |
| 120 | MP0005332_abnormal_amino_acid | 0.75189111 |
| 121 | MP0010771_integument_phenotype | 0.74673883 |
| 122 | MP0004233_abnormal_muscle_weight | 0.74427513 |
| 123 | MP0005645_abnormal_hypothalamus_physiol | 0.74425332 |
| 124 | MP0005670_abnormal_white_adipose | 0.72472223 |
| 125 | MP0001881_abnormal_mammary_gland | 0.72046708 |
| 126 | MP0002090_abnormal_vision | 0.71647350 |
| 127 | MP0001905_abnormal_dopamine_level | 0.71402380 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.70866192 |
| 129 | MP0005257_abnormal_intraocular_pressure | 0.70189291 |
| 130 | MP0003646_muscle_fatigue | 0.69960319 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.69811037 |
| 132 | MP0004134_abnormal_chest_morphology | 0.68700094 |
| 133 | MP0003938_abnormal_ear_development | 0.67012014 |
| 134 | MP0001756_abnormal_urination | 0.66048846 |
| 135 | MP0003300_gastrointestinal_ulcer | 0.65658656 |
| 136 | MP0000428_abnormal_craniofacial_morphol | 0.64762326 |
| 137 | MP0002184_abnormal_innervation | 0.62329499 |
| 138 | MP0005410_abnormal_fertilization | 0.60960343 |
| 139 | MP0003279_aneurysm | 0.59856986 |
| 140 | MP0001664_abnormal_digestion | 0.58841780 |
| 141 | MP0000631_abnormal_neuroendocrine_gland | 0.57735414 |
| 142 | MP0001986_abnormal_taste_sensitivity | 0.57313824 |
| 143 | MP0000647_abnormal_sebaceous_gland | 0.56366683 |
| 144 | MP0002752_abnormal_somatic_nervous | 0.54763717 |
| 145 | MP0003283_abnormal_digestive_organ | 0.54648042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thyroid-stimulating hormone excess (HP:0002925) | 8.90690456 |
| 2 | Interstitial pulmonary disease (HP:0006530) | 6.89223390 |
| 3 | Abnormality of binocular vision (HP:0011514) | 6.25236762 |
| 4 | Diplopia (HP:0000651) | 6.25236762 |
| 5 | Aplasia of the phalanges of the hand (HP:0009802) | 6.11245219 |
| 6 | Aplasia involving bones of the extremities (HP:0009825) | 6.11245219 |
| 7 | Aplasia involving bones of the upper limbs (HP:0009823) | 6.11245219 |
| 8 | Hemiparesis (HP:0001269) | 5.57487212 |
| 9 | Hemiplegia (HP:0002301) | 5.16050738 |
| 10 | Goiter (HP:0000853) | 5.11213502 |
| 11 | Confusion (HP:0001289) | 4.38187640 |
| 12 | Abnormality of secondary sexual hair (HP:0009888) | 4.30309798 |
| 13 | Abnormality of the axillary hair (HP:0100134) | 4.30309798 |
| 14 | Onycholysis (HP:0001806) | 3.88509797 |
| 15 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.70540500 |
| 16 | Megalencephaly (HP:0001355) | 3.64904351 |
| 17 | Facial shape deformation (HP:0011334) | 3.61100836 |
| 18 | Potter facies (HP:0002009) | 3.61100836 |
| 19 | Hypoplastic left heart (HP:0004383) | 3.46601998 |
| 20 | Pili torti (HP:0003777) | 3.42406626 |
| 21 | Hyperthyroidism (HP:0000836) | 3.36014244 |
| 22 | Atonic seizures (HP:0010819) | 3.31711576 |
| 23 | Hyperactive renin-angiotensin system (HP:0000841) | 3.30367760 |
| 24 | Focal motor seizures (HP:0011153) | 3.27844410 |
| 25 | Abnormality of nail color (HP:0100643) | 3.19883187 |
| 26 | Neonatal respiratory distress (HP:0002643) | 3.12231742 |
| 27 | Abnormal ciliary motility (HP:0012262) | 3.11013250 |
| 28 | Tetraplegia (HP:0002445) | 3.08003589 |
| 29 | Clumsiness (HP:0002312) | 3.01250220 |
| 30 | Gait imbalance (HP:0002141) | 3.00618514 |
| 31 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.99647631 |
| 32 | Hyperpituitarism (HP:0010514) | 2.99424068 |
| 33 | Rhinitis (HP:0012384) | 2.98038515 |
| 34 | Glomerulonephritis (HP:0000099) | 2.94233912 |
| 35 | Chronic bronchitis (HP:0004469) | 2.92618137 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.91089721 |
| 37 | Absent/shortened dynein arms (HP:0200106) | 2.91089721 |
| 38 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 2.88339624 |
| 39 | Respiratory distress (HP:0002098) | 2.88326254 |
| 40 | Short hallux (HP:0010109) | 2.83770133 |
| 41 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.83031588 |
| 42 | Congenital primary aphakia (HP:0007707) | 2.80370358 |
| 43 | Synostosis involving the elbow (HP:0003938) | 2.76525473 |
| 44 | Humeroradial synostosis (HP:0003041) | 2.76525473 |
| 45 | Renal tubular acidosis (HP:0001947) | 2.73375155 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 2.71826341 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.69742867 |
| 48 | Mixed hearing impairment (HP:0000410) | 2.69504123 |
| 49 | Cutaneous finger syndactyly (HP:0010554) | 2.63679070 |
| 50 | Hypoplastic heart (HP:0001961) | 2.60693240 |
| 51 | Tachypnea (HP:0002789) | 2.59065412 |
| 52 | Decreased circulating renin level (HP:0003351) | 2.58801663 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.57614978 |
| 54 | Fibular aplasia (HP:0002990) | 2.56938020 |
| 55 | Epileptic encephalopathy (HP:0200134) | 2.56544378 |
| 56 | Generalized tonic-clonic seizures (HP:0002069) | 2.53161612 |
| 57 | Split foot (HP:0001839) | 2.51032661 |
| 58 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.50486291 |
| 59 | Hyperaldosteronism (HP:0000859) | 2.48484653 |
| 60 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.47259612 |
| 61 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.47259612 |
| 62 | Subacute progressive viral hepatitis (HP:0006572) | 2.46358864 |
| 63 | Abnormality of hair growth rate (HP:0011363) | 2.43403720 |
| 64 | Slow-growing hair (HP:0002217) | 2.43403720 |
| 65 | Vaginal atresia (HP:0000148) | 2.41217568 |
| 66 | Morphological abnormality of the inner ear (HP:0011390) | 2.41147812 |
| 67 | Adactyly (HP:0009776) | 2.41034595 |
| 68 | Genital tract atresia (HP:0001827) | 2.39697188 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 2.39544674 |
| 70 | Narrow nasal bridge (HP:0000446) | 2.39264035 |
| 71 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37991218 |
| 72 | Absent hair (HP:0002298) | 2.37454795 |
| 73 | Action tremor (HP:0002345) | 2.37128386 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.36931920 |
| 75 | Focal seizures (HP:0007359) | 2.33423699 |
| 76 | Abnormality of the dental pulp (HP:0006479) | 2.32489463 |
| 77 | Nephritis (HP:0000123) | 2.32139318 |
| 78 | Laryngomalacia (HP:0001601) | 2.29347923 |
| 79 | Postural instability (HP:0002172) | 2.26488959 |
| 80 | Bronchiectasis (HP:0002110) | 2.26085351 |
| 81 | Abnormality of renin-angiotensin system (HP:0000847) | 2.25253087 |
| 82 | Abnormality of the fingertips (HP:0001211) | 2.23958075 |
| 83 | Tubulointerstitial fibrosis (HP:0005576) | 2.23848912 |
| 84 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.23341571 |
| 85 | Follicular hyperkeratosis (HP:0007502) | 2.23318795 |
| 86 | Widely patent fontanelles and sutures (HP:0004492) | 2.22036303 |
| 87 | Cutaneous syndactyly (HP:0012725) | 2.20525707 |
| 88 | Abnormal hair laboratory examination (HP:0003328) | 2.19351210 |
| 89 | Long nose (HP:0003189) | 2.17367522 |
| 90 | Hypothermia (HP:0002045) | 2.16673683 |
| 91 | Hypokalemic alkalosis (HP:0001949) | 2.14116287 |
| 92 | Abnormal urine output (HP:0012590) | 2.13644621 |
| 93 | Renal salt wasting (HP:0000127) | 2.12158021 |
| 94 | Dysdiadochokinesis (HP:0002075) | 2.11798576 |
| 95 | Bronchomalacia (HP:0002780) | 2.11002101 |
| 96 | Morphological abnormality of the middle ear (HP:0008609) | 2.08991515 |
| 97 | Complement deficiency (HP:0004431) | 2.08607422 |
| 98 | Bradycardia (HP:0001662) | 2.08531123 |
| 99 | Systemic lupus erythematosus (HP:0002725) | 2.05201101 |
| 100 | Hypothyroidism (HP:0000821) | 2.04324428 |
| 101 | Absent speech (HP:0001344) | 2.02035706 |
| 102 | Ulnar claw (HP:0001178) | 2.01255247 |
| 103 | Poor coordination (HP:0002370) | 2.00941329 |
| 104 | Abnormality of renal excretion (HP:0011036) | 2.00063518 |
| 105 | Progressive cerebellar ataxia (HP:0002073) | 2.00027522 |
| 106 | Increased circulating renin level (HP:0000848) | 1.99045196 |
| 107 | Hyperkalemia (HP:0002153) | 1.98825810 |
| 108 | Hyperventilation (HP:0002883) | 1.98529439 |
| 109 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.95417084 |
| 110 | Thickened helices (HP:0000391) | 1.94027471 |
| 111 | Paraparesis (HP:0002385) | 1.90754390 |
| 112 | Neonatal short-limb short stature (HP:0008921) | 1.90408298 |
| 113 | Metabolic alkalosis (HP:0200114) | 1.89244193 |
| 114 | Asthma (HP:0002099) | 1.89011132 |
| 115 | Renal dysplasia (HP:0000110) | 1.88393762 |
| 116 | Cerebral inclusion bodies (HP:0100314) | 1.87711592 |
| 117 | Status epilepticus (HP:0002133) | 1.87647576 |
| 118 | Lower limb hyperreflexia (HP:0002395) | 1.87399106 |
| 119 | Increased CSF protein (HP:0002922) | 1.86152997 |
| 120 | Portal hypertension (HP:0001409) | 1.85177362 |
| 121 | Abnormality of the periventricular white matter (HP:0002518) | 1.84847405 |
| 122 | Tetraparesis (HP:0002273) | 1.84794065 |
| 123 | Craniofacial hyperostosis (HP:0004493) | 1.84375163 |
| 124 | Blepharitis (HP:0000498) | 1.84144504 |
| 125 | Alacrima (HP:0000522) | 1.84142028 |
| 126 | Taurodontia (HP:0000679) | 1.79999654 |
| 127 | Abnormality of permanent molar morphology (HP:0011071) | 1.79999654 |
| 128 | Abnormality of the dental root (HP:0006486) | 1.79999654 |
| 129 | Adrenal overactivity (HP:0002717) | 1.78876961 |
| 130 | Maternal diabetes (HP:0009800) | 1.78854521 |
| 131 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.78361803 |
| 132 | Abnormality of the diencephalon (HP:0010662) | 1.78235940 |
| 133 | Neoplasm of the heart (HP:0100544) | 1.77980562 |
| 134 | Hypoplasia of the iris (HP:0007676) | 1.77520408 |
| 135 | Purpura (HP:0000979) | 1.77386628 |
| 136 | Thyroid carcinoma (HP:0002890) | 1.77363878 |
| 137 | Hypoplasia of the ulna (HP:0003022) | 1.76732467 |
| 138 | Overgrowth (HP:0001548) | 1.76218742 |
| 139 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.75560841 |
| 140 | Oligodactyly (hands) (HP:0001180) | 1.74844008 |
| 141 | Large for gestational age (HP:0001520) | 1.73493971 |
| 142 | Abnormality of molar morphology (HP:0011070) | 1.73051535 |
| 143 | Abnormality of molar (HP:0011077) | 1.73051535 |
| 144 | Hoarse voice (HP:0001609) | 1.72312509 |
| 145 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.71163987 |
| 146 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.70630902 |
| 147 | Tubulointerstitial abnormality (HP:0001969) | 1.70323919 |
| 148 | Short middle phalanx of the 5th finger (HP:0004220) | 1.70126435 |
| 149 | Broad alveolar ridges (HP:0000187) | 1.69830144 |
| 150 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.69376953 |
| 151 | Abnormal eating behavior (HP:0100738) | 1.68708794 |
| 152 | Intention tremor (HP:0002080) | 1.67856780 |
| 153 | Alopecia of scalp (HP:0002293) | 1.67659771 |
| 154 | Blue irides (HP:0000635) | 1.67453956 |
| 155 | Back pain (HP:0003418) | 1.66316811 |
| 156 | Truncal ataxia (HP:0002078) | 1.65857188 |
| 157 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.65420600 |
| 158 | Absent toe (HP:0010760) | 1.65027344 |
| 159 | Left ventricular hypertrophy (HP:0001712) | 1.64490565 |
| 160 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.64468828 |
| 161 | Pheochromocytoma (HP:0002666) | 1.64345200 |
| 162 | Cranial hyperostosis (HP:0004437) | 1.64163813 |
| 163 | Corneal erosion (HP:0200020) | 1.63153258 |
| 164 | True hermaphroditism (HP:0010459) | 1.60796155 |
| 165 | Broad hallux (HP:0010055) | 1.59919559 |
| 166 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.59718743 |
| 167 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.58507013 |
| 168 | Pseudobulbar signs (HP:0002200) | 1.57875632 |
| 169 | Brittle hair (HP:0002299) | 1.57153124 |
| 170 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.56071328 |
| 171 | Abnormality of the nasal septum (HP:0000419) | 1.55813986 |
| 172 | Multifactorial inheritance (HP:0001426) | 1.54700425 |
| 173 | Hypoplastic nipples (HP:0002557) | 1.54437099 |
| 174 | Progressive sensorineural hearing impairment (HP:0000408) | 1.54393924 |
| 175 | Microglossia (HP:0000171) | 1.53852894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 7.05264454 |
| 2 | MST1R | 4.57233636 |
| 3 | MAPK15 | 4.40380185 |
| 4 | PRKD3 | 3.50031798 |
| 5 | CASK | 3.11945345 |
| 6 | NTRK2 | 2.86427893 |
| 7 | EPHA2 | 2.66093266 |
| 8 | MET | 2.62642154 |
| 9 | PHKG2 | 2.44151809 |
| 10 | PHKG1 | 2.44151809 |
| 11 | EPHA4 | 2.32223862 |
| 12 | EPHA3 | 2.25979208 |
| 13 | INSRR | 2.24699966 |
| 14 | MUSK | 2.19216359 |
| 15 | CAMK1G | 2.17244655 |
| 16 | MST4 | 2.11374821 |
| 17 | FRK | 2.11288087 |
| 18 | MAPK13 | 2.07968829 |
| 19 | CAMK1D | 2.05504646 |
| 20 | PDK2 | 2.04950451 |
| 21 | SGK2 | 1.99847678 |
| 22 | NTRK3 | 1.93623211 |
| 23 | SIK1 | 1.89246129 |
| 24 | MKNK2 | 1.77449990 |
| 25 | SGK3 | 1.77175267 |
| 26 | LMTK2 | 1.72764353 |
| 27 | FER | 1.69964567 |
| 28 | SGK223 | 1.55072298 |
| 29 | SGK494 | 1.55072298 |
| 30 | PIK3CA | 1.45706995 |
| 31 | MAPK12 | 1.45134155 |
| 32 | MARK1 | 1.44252426 |
| 33 | MAP2K7 | 1.43043354 |
| 34 | MAP3K13 | 1.41580945 |
| 35 | MAP3K6 | 1.38594859 |
| 36 | PRKD2 | 1.37939465 |
| 37 | IRAK3 | 1.33073882 |
| 38 | MAP3K4 | 1.31462063 |
| 39 | NEK6 | 1.27373293 |
| 40 | STK38L | 1.25008060 |
| 41 | LRRK2 | 1.11969582 |
| 42 | MAP3K2 | 1.11438842 |
| 43 | RIPK1 | 1.10669251 |
| 44 | PRKAA2 | 1.09669082 |
| 45 | TIE1 | 1.06612422 |
| 46 | PRKCG | 1.04162187 |
| 47 | PRKCH | 0.99669102 |
| 48 | MAP3K7 | 0.98064353 |
| 49 | RET | 0.97612103 |
| 50 | RIPK4 | 0.91900142 |
| 51 | LATS1 | 0.91531491 |
| 52 | PRKCE | 0.91074582 |
| 53 | FGFR2 | 0.89619890 |
| 54 | EPHB1 | 0.89422771 |
| 55 | GRK1 | 0.88282953 |
| 56 | ERBB4 | 0.87610599 |
| 57 | PDGFRB | 0.87521001 |
| 58 | MINK1 | 0.86504862 |
| 59 | FES | 0.86306621 |
| 60 | TRPM7 | 0.86301067 |
| 61 | NLK | 0.85331599 |
| 62 | AKT3 | 0.85280769 |
| 63 | BMX | 0.80794931 |
| 64 | PINK1 | 0.78713658 |
| 65 | FGFR4 | 0.78440787 |
| 66 | FGR | 0.78221588 |
| 67 | TNK2 | 0.75125175 |
| 68 | DYRK1A | 0.74745936 |
| 69 | NTRK1 | 0.74285677 |
| 70 | PAK6 | 0.70651666 |
| 71 | CDK5 | 0.70541949 |
| 72 | PKN1 | 0.69783520 |
| 73 | CAMK2G | 0.69632798 |
| 74 | CSNK1A1L | 0.68135608 |
| 75 | SGK1 | 0.67872521 |
| 76 | CAMK2A | 0.65866505 |
| 77 | MAP3K3 | 0.64864987 |
| 78 | ROCK1 | 0.64724778 |
| 79 | PTK2B | 0.64251737 |
| 80 | MAPK7 | 0.63862313 |
| 81 | CDC42BPA | 0.63717578 |
| 82 | MAP2K4 | 0.62850053 |
| 83 | WNK1 | 0.62759039 |
| 84 | ADRBK1 | 0.62172152 |
| 85 | PRPF4B | 0.62037570 |
| 86 | STK38 | 0.61403722 |
| 87 | MAPKAPK3 | 0.59904798 |
| 88 | ERBB3 | 0.59515641 |
| 89 | FGFR3 | 0.59499440 |
| 90 | TYRO3 | 0.58556267 |
| 91 | JAK2 | 0.56838711 |
| 92 | CAMK1 | 0.56477168 |
| 93 | IGF1R | 0.56439317 |
| 94 | MARK2 | 0.55970565 |
| 95 | BCR | 0.55717358 |
| 96 | YES1 | 0.55140346 |
| 97 | FGFR1 | 0.53641184 |
| 98 | IRAK1 | 0.53607645 |
| 99 | MAP3K9 | 0.52611433 |
| 100 | EGFR | 0.51659797 |
| 101 | PAK3 | 0.51101763 |
| 102 | PRKCA | 0.51011083 |
| 103 | CSNK1G2 | 0.50280721 |
| 104 | PRKG1 | 0.50004087 |
| 105 | KSR1 | 0.48899969 |
| 106 | TRIB3 | 0.48209659 |
| 107 | TAOK3 | 0.47931069 |
| 108 | PRKCQ | 0.47252210 |
| 109 | CDK3 | 0.46956484 |
| 110 | NEK9 | 0.46945217 |
| 111 | AKT2 | 0.46347106 |
| 112 | PRKAA1 | 0.46282563 |
| 113 | CSNK1G1 | 0.46036533 |
| 114 | GSK3A | 0.44676728 |
| 115 | BMPR1B | 0.44505684 |
| 116 | STK24 | 0.44486877 |
| 117 | JAK1 | 0.44379228 |
| 118 | PRKACG | 0.43880345 |
| 119 | PRKD1 | 0.43777129 |
| 120 | CAMK2B | 0.43200432 |
| 121 | MAPK11 | 0.43123315 |
| 122 | PDPK1 | 0.42716421 |
| 123 | PNCK | 0.42468402 |
| 124 | PRKACA | 0.40308267 |
| 125 | RPS6KA3 | 0.40181233 |
| 126 | DDR2 | 0.40022916 |
| 127 | PDK1 | 0.39709175 |
| 128 | ROCK2 | 0.39460007 |
| 129 | PRKCZ | 0.38946514 |
| 130 | ABL1 | 0.38557918 |
| 131 | ERBB2 | 0.38404480 |
| 132 | RPS6KA2 | 0.37897082 |
| 133 | DAPK2 | 0.36963055 |
| 134 | OXSR1 | 0.36885621 |
| 135 | DMPK | 0.36339631 |
| 136 | SRC | 0.35709268 |
| 137 | BRSK2 | 0.35604142 |
| 138 | CSNK1A1 | 0.34274876 |
| 139 | PRKCB | 0.32957832 |
| 140 | STK39 | 0.32530842 |
| 141 | MAPK10 | 0.31537436 |
| 142 | FYN | 0.31120175 |
| 143 | RPS6KB1 | 0.30283394 |
| 144 | STK11 | 0.29640902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 6.34954896 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.77050497 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.46829089 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.61030690 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.58624811 |
| 6 | Salivary secretion_Homo sapiens_hsa04970 | 2.01752432 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 1.89553222 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.86519314 |
| 9 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85002634 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81787878 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78558277 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.77846097 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72485036 |
| 14 | Mineral absorption_Homo sapiens_hsa04978 | 1.69468487 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.66971160 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.66367436 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.65690472 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.50401716 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41681605 |
| 20 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.38863291 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36613892 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.32699054 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.32054733 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.31781121 |
| 25 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.30470072 |
| 26 | Adherens junction_Homo sapiens_hsa04520 | 1.26450347 |
| 27 | Tight junction_Homo sapiens_hsa04530 | 1.23044205 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19745330 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19294370 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.17699123 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14828625 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13767522 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.12440234 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11073738 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08839291 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08645973 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08170059 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06521389 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05555956 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03774262 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01477809 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00342914 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99821840 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99625915 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98906965 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.96761315 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93825530 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92113282 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90984870 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90096699 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 0.89571554 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.88778649 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88604750 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.87538561 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87373263 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.84686806 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83531272 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 0.83280739 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82233775 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81915965 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81611412 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81472102 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79505928 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78952996 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.78407275 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78387802 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76135691 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76075581 |
| 69 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.74105459 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72693780 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72301992 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72230935 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72074742 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72068811 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71456968 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.69025647 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68860708 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66317071 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.65650225 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65241108 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65098891 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64221294 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63814551 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62801885 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61414094 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61201191 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58157809 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57189175 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56448190 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.56443903 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.56365696 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55658968 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55191577 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53805158 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.53754180 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53653895 |
| 97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51542295 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50783217 |
| 99 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49813462 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49776171 |
| 101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49427582 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48665085 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48276632 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47447092 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46464579 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.45796087 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45780273 |
| 108 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43419400 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41319812 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.41059891 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39952888 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39603713 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.38849313 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38043658 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36918015 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35961324 |
| 117 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33845229 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33696474 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33619273 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33075007 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33054343 |
| 122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31613941 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30458516 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.29667955 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29654719 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26871236 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26195474 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25632357 |
| 129 | Malaria_Homo sapiens_hsa05144 | 0.23560846 |
| 130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23475413 |

